@article{7397cf37de4d46cc8b3428bf83ed6a95,
title = "Imatinib mesilate: New perspectives in the treatment of solid tumours",
keywords = "BCR-ABL, Biological therapy, C-kit, Drug Discovery3003 Pharmaceutical Science, Gastrointestinal stromal tumours, Imatinib mesilate, Neoplasm, Pharmacology, Platelet-derived growth factor receptor, Protein-tyrosine kinase, BCR-ABL, Biological therapy, C-kit, Drug Discovery3003 Pharmaceutical Science, Gastrointestinal stromal tumours, Imatinib mesilate, Neoplasm, Pharmacology, Platelet-derived growth factor receptor, Protein-tyrosine kinase",
author = "Carlo SMIRNE and Anna Carbone and Mario PIRISI and Graziella Bellone",
year = "2006",
month = jan,
day = "1",
doi = "10.1517/13543776.16.10.1359",
language = "English",
volume = "16",
pages = "1359--1370",
journal = "Expert Opinion on Therapeutic Patents",
issn = "1354-3776",
publisher = "Taylor and Francis Ltd.",
number = "10",
}